Management of Early Triple Negative Breast Cancer

Management of early triple-negative breast cancer (TNBC) requires a comprehensive approach to ensure optimal outcomes. Early TNBC refers to breast cancer that is diagnosed at an early stage, before it has spread to lymph nodes or distant sites. The management of early TNBC typically involves a combination of surgery, radiation therapy, and systemic treatments. Surgery is the primary treatment for early TNBC and usually involves a lumpectomy or mastectomy. Lumpectomy involves removing the tumor and a small margin of surrounding healthy tissue, while mastectomy involves removing the entire breast. The choice between lumpectomy and mastectomy depends on various factors, including tumor size, location, and patient preference. Following surgery, radiation therapy is often recommended to reduce the risk of cancer recurrence in the breast. Systemic treatments, such as chemotherapy, targeted therapy, and hormonal therapy, are commonly used in the management of early TNBC.